Rafał Krygier

5PUBLICATIONS
13CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 30, 2023
Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens.

Olga Tronina, Michał Brzdęk, Dorota Zarębska-Michaluk

|Sep 09, 2022
Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study.

Paweł Rajewski, Dorota Zarębska-Michaluk, Ewa Janczewska

|Jan 21, 2022
Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection.

Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Anna Parfieniuk-Kowerda

|Jan 21, 2022
HCV Genotype Has No Influence on the Incidence of Diabetes-EpiTer Multicentre Study.

Paweł Rajewski, Dorota Zarębska-Michaluk, Ewa Janczewska

|Aug 07, 2021
Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics.

Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Anna Parfieniuk-Kowerda

Pageof 1